Aurinia Pharmaceuticals Inc.
-
Ticker
AUPH
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Victoria, British Columbia
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis and Dry Eye Syndrome. The company is
…More headquartered in Victoria, British Columbia, its U.S. commercial hub in Rockville, MD, and focuses its development efforts globally.
REPORT RATINGS
5.0 / 5.0 (1)
Aurinia Pharmaceuticals Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Aurinia Pharmaceuticals Inc.
Most Recent Responsibility Report
MOST RECENT
2023 ESG Report
Report Locked. Aurinia Pharmaceuticals Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Aurinia Pharmaceuticals Inc. Sustainability Report, Aurinia Pharmaceuticals Inc. Corporate Social Responsibility Report, Aurinia Pharmaceuticals Inc. CSR Report, Aurinia Pharmaceuticals Inc. Corporate Responsibility, Aurinia Pharmaceuticals Inc. CR Report, Aurinia Pharmaceuticals Inc. Citizenship Report, Aurinia Pharmaceuticals Inc. ESG Report, and Aurinia Pharmaceuticals Inc. Environmental Report online.